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THE LANCET • Vol 363 • May 29, 2004 • www.thelancet.com CORRESPONDENCE thought to cause SARS and propose that non-pneumonic infections are more common than SARS virus pneumonia in Hong Kong. However, I worry that the method used by Woo and colleagues could have led to a misleading concept. Although the authors claim that they used western blot to confirm the specificity of antibodies against SARS-correlated virus, the method they used, which was based on a recombinant nucleocapsid protein and a recombinant spike polypeptide blotted onto membranes to probe corresponding antibodies, is actually a dot-blot ELISA.
Western blot only shows high specificity in detecting antigens when used with known specific antibodies. False-positive reactions in ELISA can be caused by the binding of lowaffinity polyreactive antibodies. Therefore, I am not convinced that the antibodies detected in the four individuals without SARS in Woo and colleagues' report were specific to the SARS virus. The specificity of such antibodies in non-SARS cases needs to be confirmed by a viral neutralisation assay. Indeed, nine other samples that were weakly positive for antibodies against SARS virus by a dot-blot ELISA were all negative by a viral neutralisation test. 2 Several reports have documented subclinical and mild infections with SARS virus in individuals who had been in close contact with patients with SARS. Li and colleagues 3,4 reported that of 125 people exposed to SARS patients, 20 developed SARS with seroconversion of antibodies against SARS virus, 103 were negative for such antibodies, and only two had non-pneumonic infections confirmed by detection of the specific antibodies. Ho and colleagues 5 also found that SARS-virus pneumonia was more common than non-pneumonic infections in people who had histories of contact with patients with SARS. The fact that the SARS outbreaks occurred in spring 2003 and were contained by mid-July after each of the cases of probable or suspect SARS was quarantined or sequestered also suggests that subclinical infections with SARS virus in the general population are rare.
Subclinical or non-pneumonic SARS-virus infections do exist; however, such infections are less common than apparent infections after exposure to SARS. should be drawn between this cumulative incidence figure and the pneumonic SARS cumulative incidence for the adult population of Hong Kong. Similarly, if it is fair to assume that the other study groups are representative of some broader community group, these cumulative incidence figures could be compared, although care in interpretation would need to be taken given the low numbers in the study population.
Yi-Hua Zhou
The overall study population, however, is unlikely to be representative of the entire Hong Kong population and therefore conclusions drawn by comparing pneumonic SARS illness in Hong Kong with the cumulative incidence of antibodies to SARS coronavirus in the study population is fraught with danger. This situation arises particularly given the known effect of age and chronic medical conditions on the epidemiology of SARS, but could well be influenced by other (known and unknown) confounders too. Sir-Patrick Woo and colleagues' findings 1 are certainly pertinent to health-care-system planning for potential SARS outbreaks. However, I wish to express my concern over the comparison of a figure reported as a rate for the study population with the cumulative incidence of pneumonic SARS for the Hong Kong population.
Megan Young
The rate for the study population consists of one non-pneumonic paediatric patient and three blood donors with positive results divided by the overall number tested in the study. I would argue that the one paediatric patient with a compatible illness divided by the total paediatric study population represents the cumulative incidence for non-pneumonic SARS in that population alone (which might or might not be representative of the total paediatric inpatient population over the study period or the paediatric population of Hong Kong).
With respect to the blood donors, unless these people were identified, I believe it would be impossible to know whether or not they had pneumonic or non-pneumonic SARS, or whether their illness was in fact within the study period. Assuming these three people were not among the 1728 who were known to have developed SARS pneumonia, and assuming no one in Hong Kong was exposed to SARS coronavirus before March, 2003, these three confirmed cases divided by the total number of blood donors in the study population would represent the cumulative incidence of non-pneumonic SARS in this population (which again might or might not be representative of all blood donors, depending on whether they were selected at random and might or might not be representative of the wider Hong Kong adult population).
If we accept that the blood donors are likely to be representative of the adult population of Hong Kong, comparison
